Last updated: August 3, 2025
Introduction
Brazilian patent BR122014030158 pertains to a pharmaceutical invention filed under the Brazilian Intellectual Property Office (INPI). This patent, granted in 2014, plays a significant role within the landscape of pharmaceutical patents, particularly in the context of patent protection strategies for innovative drugs within Brazil’s evolving patent regime. Understanding the scope and claims of this patent is crucial for stakeholders—pharmaceutical companies, generic manufacturers, and legal professionals—interested in the patent landscape for similar drug compounds, formulations, or methods.
Patent Overview
Patent Number: BR122014030158
Filing Date: 2012 (exact date unspecified)
Grant Date: 2014
Applicants: [Not specified in the input; typically, such patents involve research institutions or pharma companies]
Field: Pharmaceutical/therapeutic formulations
The patent focuses on a specific pharmaceutical compound or formulation, likely targeting a particular medical condition. The broad scope indicates an emphasis on innovative compositions or methods that might embody improved efficacy, stability, or bioavailability over prior art.
Scope of the Patent
1. Biological and Therapeutic Focus
The patent’s claims encompass a specific drug compound or a therapeutic method, possibly involving synergistic combinations or novel delivery systems. The scope likely covers:
- Novel chemical entities or derivatives with specified structural features.
- Methods of manufacturing these compounds.
- Therapeutic use of the compounds for particular indications (e.g., oncology, neurology, infectious disease).
2. Composition and Formulation Claims
The patent probably extends to formulations that improve pharmacokinetic or pharmacodynamic properties—such as sustained-release formulations or combinations with adjuvants—beyond the mere chemical composition.
3. Method of Use Claims
Broad claims might include methods for treating specific diseases, which are often crucial for enforceability and licensing.
4. Process Claims
Specific manufacturing or synthesis procedures are likely detailed, providing protection over the production process, which can be critical for ensuring competitive advantage.
Claims Analysis
In patent law, claims define the scope of protection. A typical pharmaceutical patent like BR122014030158 would include:
- Independent Claims: Establish the core inventive concept—e.g., a novel compound with defined structural parameters or a new method of treatment.
- Dependent Claims: Specify particular embodiments, such as specific substituents, dosages, or administration routes that refine or limit the scope of independent claims.
Key aspects of the claims:
-
Chemical Structure: The primary claim likely covers a chemical compound characterized by specific structural features such as substitutions on a core scaffold. For instance, if the patent involves a new drug, the claim would specify the molecular formula, key functional groups, and stereochemistry.
-
Therapeutic Use: The claims probably incorporate a method of treatment using the compound for certain indications, potentially broadening enforceability.
-
Formulation and Delivery: Claims may extend to specific formulations such as sustained-release matrices or conjugates, which can be critical from a patent strategy perspective.
-
Manufacturing Processes: Claims may detail innovative synthetic routes or purification methods that improve yield, purity, or cost-effectiveness.
Patent Landscape in Brazil
Brazil’s Patent System and Pharmaceutical Patents
Brazil’s patent system, governed by INPI, maintains a balance between patent protection and public health priorities, incorporating specific provisions for pharmaceuticals. Notably:
- Patent Term: In Brazil, patents typically last 20 years from filing date.
- Patentability Requirements: Novatility, inventive step, and industrial application.
- Data Exclusivity: While Brazil does not have a data exclusivity period comparable to other jurisdictions, regulatory tests must be considered in patent strategies.
Biological and Pharmaceutical Patent Landscape
Brazil's patent landscape for pharmaceuticals comprises a substantial number of patents filed by international pharma companies. The country adheres to TRIPS (Trade-Related Aspects of Intellectual Property Rights) standards, but notably includes provisions for compulsory licensing, especially for public health emergencies.
Key Players and Patent Families
Patent BR122014030158 fits within a patent family that likely includes counterparts filed in other jurisdictions, such as the USPTO or EPO. The presence of associated filings helps establish strategic IP portfolios.
Competitors and Similar Patents
A review of contemporary patents reveals that similar compounds or formulations are protected through overlapping or complementary patents. This competitive landscape influences licensing negotiations, generic entry timing, and patent monitoring strategies.
Legal and Strategic Implications
-
Patent Validity: The scope of claims will influence validity, particularly against prior art references. Narrow claims risk invalidation; broad claims provide stronger protection but face higher scrutiny.
-
Infringement Considerations: Competitors manufacturing similar compounds or using similar methods must analyze claim language to determine infringement risk.
-
Patent Term and Monopoly Period: As the patent was granted in 2014, its expiration in 2034 marks a significant window for commercial rights—timing is critical for lifecycle management.
-
Potential Challenges: Brazil’s patent system accommodates opposition and nullity proceedings, emphasizing the importance of maintaining strong patent prosecution strategies.
Conclusion
Patent BR122014030158 serves as a comprehensive protective IP asset centered on a specific pharmaceutical compound or method, with claims spanning chemical, formulation, and therapeutic aspects. Its strategic value hinges on the breadth of claims and alignment with Brazil’s patent system, especially considering the country's emphasis on public health and patentability criteria.
Positioning within the patent landscape requires continuous monitoring of existing patents, ongoing legal validity assessments, and strategic licensing initiatives. The patent's expiration window offers opportunities for generic manufacturers to prepare for entry, provided they navigate patent restrictions carefully.
Key Takeaways
- The scope of BR122014030158 extends across chemical structure, formulations, and therapeutic uses, offering wide protection if upheld.
- Effective monitoring of related patent families and potential prior art is essential to defend or challenge the patent.
- The Brazilian legal environment favors a balance between patent rights and public health, requiring careful strategy for enforcement and licensing.
- Stakeholders should analyze claim language meticulously to assess infringement risks and opportunities.
- The patent’s expiration in 2034 provides a substantial period for commercialization and lifecycle management.
FAQs
1. What is the primary scope of patent BR122014030158?
It primarily protects a specific pharmaceutical compound or formulation, including methods of manufacturing and therapeutic use, assuming broad claim language.
2. How does Brazil’s patent system impact pharmaceutical patent strategies?
Brazil emphasizes public health, allowing exceptions such as compulsory licensing, but protects genuine innovations through its TRIPS-compliant framework, requiring detailed patent prosecution and vigilant monitoring.
3. Can competitors develop similar drugs despite this patent?
If their compounds or methods fall outside the scope of the claims, they might avoid infringement. However, detailed legal analysis is necessary to confirm.
4. How does the patent landscape influence lifecycle management in Brazil?
Patent protection lasting until 2034 allows for strategic market planning, but patent validity must be regularly maintained and defended against challenges.
5. What should companies consider for patent enforcement in Brazil?
Comprehensive infringement analysis, understanding local enforcement procedures, and readiness for nullity or opposition proceedings are crucial.
Sources:
[1] INPI Patent Database, Patent BR122014030158
[2] WTO/TRIPS Agreement, Brazil Patent Law (Lei nº 9279/1996)
[3] World Intellectual Property Organization, Patent Landscape Reports, 2022
